|[January 08, 2013]
Research and Markets: Choroidal Neovascularization - Pipeline Review, H2 2012
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/5llnvq/choroidal)
has announced the addition of Global Markets Direct's new report
"Choroidal Neovascularization - Pipeline Review, H2 2012" to their
Global Markets Direct's, 'Choroidal Neovascularization - Pipeline
Review, H2 2012', provides an overview of the indication's therapeutic
pipeline. This report provides information on the therapeutic
development for Choroidal Neovascularization, complete with latest
updates, and special features on late-stage and discontinued projects.
It also reviews key players involved in the therapeutic development fr
Choroidal Neovascularization. Choroidal Neovascularization - Pipeline
Review, Half Year is built using data and information sourced from
Global Markets Direct's proprietary databases, Company/University
websites, SEC (News - Alert) filings, investor presentations and featured press
releases from company/university sites and industry-specific third party
sources, put together by Global Markets Direct's team.
- A snapshot of the global therapeutic scenario for Choroidal
- A review of the Choroidal Neovascularization products under
development by companies and universities/research institutes based on
information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging
from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and
- Coverage of the Choroidal Neovascularization pipeline on the basis of
route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
For more information visit http://www.researchandmarkets.com/research/5llnvq/choroidal
Source (News - Alert): Global Markets Direct
[ Back To TMCnet.com's Homepage ]